AEON Biopharma, Inc.
Symbol: AEON (NYSE)
0.00
▼ (-100.00%) -0.770
Company Description:
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $0.77
- Yesterday High: $0.7857
- Yesterday Low: $0.721
- Yesterday Volume: 151.80K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: AEON Biopharma, Inc.
- Website: https://www.aeonbiopharma.com
- Listed Date: 2023-07-24
- Location: IRVINE, CA
- Market Status: Active
- CIK Number: 0001837607
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $10.08M
- Round Lot: 100
- Outstanding Shares: 11.31M
- Asset Type: CS
RECENT FILINGS FOR AEON
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-06-16 | 424B5 | View |
| 2025-06-13 | 8-K | View |
| 2025-06-11 | 10-Q/A | View |
| 2025-06-11 | 10-K/A | View |
| 2025-06-11 | DEFR14A | View |
| 2025-05-30 | SCHEDULE 13G | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-23 | 4 | View |
| 2025-05-21 | 4 | View |
| 2025-05-20 | 8-K | View |
| 2025-05-16 | 4 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on AEON